Navigation Links
Allergy Shots May Soon be a Thing of the Past.

Allergy shots may soon be replaced by a pill according to European researchers. The latest study supports previous research which showed the effectiveness of the Grazax allergen tablet.// Hay fever and other allergies have long been treated with allergy shots.

Allergies are a result of the immune system reacting to a normally harmless substance, such as dust mites.

Immunotherapy is supposed to enhance tolerance of the immune system for the allergy-causing substance by exposing the body to small amounts of it over time.

The inconvenience and discomfort of immunotherapy often deters allergy sufferers from getting immunotherapy.

Patients must get weekly allergy shots for several months, and then monthly ones for several years.

Dr. Ronald Dahl of Aarhus University in Denmark proposes that Grazax, a grass allergen tablet, rapidly dissolves under the tongue and this could be an easier alternative for patients.

Grazax has already been approved in Sweden and its manufacturer, ALK-Abello, is applying for approval in other European countries.


NLA
'"/>




Page: 1

Related medicine news :

1. Allergy Risk Increased by Kerosene Use
2. Infant Fevers Found to Reduce Allergy Risk Later In Life
3. A Common Cause Of Allergy That Goes Unnoticed
4. Laser Surgery for Allergy
5. The Efficacy Of Allergy Shots Questioned
6. Oral Edible vaccine for Allergy Vaccines
7. Tattoo Wearers Are More Prone To Allergy Risks
8. A Sneak Preview of Human’s Susceptibility to Auto Immune Disease, Allergy, Asthm
9. Allergy Alarm: Sams Choice Milk Chocolate Turns Bitter with Undisclosed Nuts
10. Hope for Dust Mite Allergy Sufferers
11. Effective Vaccine Found For Dust Mite Allergy
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Allergy Shots May Soon Thing the Past

(Date:9/5/2008)...stive and Kidney Diseases (NIDDK), part of the Nat... to eight academic research centers to conduct col... disorders by looking for clues outside the bladde...the five-year project is estimated to be up to $37... effort is an excellent example of NIH,s commitmen...
(Date:9/5/2008)... -- As the general election,campaign begins in ear...,Business ( http://www.nfib.com ) is looking to th...on the healthcare concerns of small,business. Now ... over, NFIB,is asking both candidates to fully con...inesses as they further develop their healthcare p...
(Date:9/5/2008)...are enhanced by taking into account risk factors b...ding to research teams led by epidemiologists at T...r in two complementary papers appearing in the Sep...In the first study to focus on African-Americans, ...d exposure to certain risks. Based upon these find...
(Date:9/4/2008)... presence of measles virus RNA was no more likely ...n children with only GI disturbances. Furthermore...R vaccine timing. Study findings are reported onl...r 4 ( http://dx.plos.org/10.1371/journal.pone.0003...vaccines in 1963, three to four million people wer...
Breaking Medicine News(10 mins):Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3
...rs at the Kimmel Cancer Center at Thomas Jefferson...al in Philadelphia, shows that pancreatic cancer p... after surgery have nearly as good a chance as any...esearchers reviewed the records of 890 patients wi...
...g patients, warns a senior doctor in this week’s B...monest causes of delayed discharge are associated ..., healthcare acquired infections, and medication e...result of lack of trained staff, lack of continuit...
...tients between the ages of 55 and 64 in the United...86 surgeries in 2004—a nearly 2,000 percent increa... Healthcare Research and Quality. The report, the...as done on obesity surgery, also found a 726 perce...
...s bit scores of people in the Pakistani city of Ra...uld be cornered and killed, media reports said Sat...n city Friday, the sick animals set upon on a tota...women and children on their way to school and work...
Other Medicine News:Health News:Study: Older Pancreatic Cancer Surgery Survivors Live Long 2Health News:Obesity Surgeries Have Jumped Dramatically Since 1998 2
(Date:9/4/2008)...iral activity and favorable safety ... 4 /- Idenix,Pharmaceutical...any engaged,in the discovery and development of dr...ectious diseases, today announced that it has comp..., a non-nucleoside reverse,transcriptase inhibitor...
(Date:9/3/2008)...Children Studied. Wrong,Conclusions Reached., NIX...rs for Disease,Control and Prevention (CDC) study ... MMR vaccine and autism. The National Autism Assoc...l the growing public concern over a,vaccine-autism...g design,and methodology., For years, parents hav...
(Date:9/3/2008)... Disease Awareness Month, CHARLOTTESVILLE, Va., S...LC, a clinical-stage drug-development company comm...edical needs, announced today that it has begun,to... its lead drug,candidate trans sodium crocetinate ...inicaltrials.gov Website, is investigating TSC as ...
(Date:9/3/2008)... 3 Plans with FDA, PRINCETON, N.J., Sept. 3 /PRNe...ay that it successfully completed two key clinical...nnovative low-dose, once-weekly,contraceptive pat...oduct,code AG-200-15. The Phase 2b safety and effi...f ovulation suppression, cycle control and safety....
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 1PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 2PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 3PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 4PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 5Sleep Apnea Screening Cuts Surgical Complications 17520 1Sleep Apnea Screening Cuts Surgical Complications 17520 2Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 1Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 2Ceregene Announces Two Key Additions to Leadership Team 4799 1Ceregene Announces Two Key Additions to Leadership Team 4799 2Ceregene Announces Two Key Additions to Leadership Team 4799 3
...diac surgery patients require progressive solution...urn to everyday life. Since the introduction of e... been able to provide nearly 400,000 CABG patients...ulation , Shorter hospital stays , Reduced ris...
...corrected with GP lenses. Even though good spectac...p the patient adapt to the inevitable. GP lenses w...ace and provide improved visual acuity., ,Keratoco...ienced practitioner. Each case is unique and requi...
...ted Immunoassay Analyzer that fits in any lab envi... X 21 inches and weighs approximately 60 lbs. Its...ratories, work stations for small hospitals, STAT ...cated system for specialty testing. With a throug...
... winning the hearts of cardiologists and cardiac p...operative words for Heartline™. Patients con...nd their attending physician know that a professio...n is only a phone call away. ,Heartline™ ...
Medicine Products: